Sameer Kejriwal , Edward Weldon , Davis Carter , Keinan Agonias , Jacob Razzouk , Daniel Bohen , Omar Ramos , Olumide Danisa , Wayne Cheng
{"title":"Analysis of reasons for medical malpractice litigation due to spinal cord stimulator","authors":"Sameer Kejriwal , Edward Weldon , Davis Carter , Keinan Agonias , Jacob Razzouk , Daniel Bohen , Omar Ramos , Olumide Danisa , Wayne Cheng","doi":"10.1016/j.inpm.2023.100376","DOIUrl":null,"url":null,"abstract":"<div><h3>Study design</h3><p>Retrospective cohort study.</p></div><div><h3>Introduction</h3><p>Malpractice claims analysis is performed by several specialties to improve quality of patient care and to identify areas where physicians can improve their practice to mitigate the incidence of committing malpractice. The Food and Drug Administration has flagged over 80,000 injuries caused by spinal cord stimulator (SCS), making them the 3rd most flagged medical device. This study analyzed malpractice claims due to SCS by querying two legal databases widely used in medicolegal research.</p></div><div><h3>Methods</h3><p>Westlaw Edge and VerdictSearch were queried for malpractice cases filed between the years 2000 and 2022 using the keywords “spinal cord stimulator.” Case inclusion criteria was defined as a plaintiff's basis of litigation resting on a claim of medical malpractice due to SCS. Additional data collected included date of case hearing, plaintiff sex and age, defendant specialty, verdict ruling, location of the filed claim, payment or settlement amount, and sustained injuries.</p></div><div><h3>Result</h3><p>Of the 1773 reviewed cases, 45 cases were included and categorized as battery or implantable pulse generator malfunction (35.56 %), lead complications (28.89 %), surgical complications (20.00 %), and miscellaneous (15.56 %). Four (8.89 %) cases resulted in settlement, 11 (24.44 %) in a plaintiff verdict, and 30 (68.00 %) resulted in a defendant verdict. Claims filed due to infection related to SCS were more likely to result in a defendant verdict (<em>p</em> = .047), whereas claims filed due to neurological deficit were more likely to result in a plaintiff verdict (<em>p</em> = .020). The average settlement amount for the 4 cases is $1,975,309.61.</p></div><div><h3>Conclusion</h3><p>Our findings suggest obtaining adequate neuroimaging preoperatively with MRIs, disclosing neurological risks specifically paralysis on informed consent, and evaluating radiography intraoperative and postoperatively with anterior-posterior (AP) and lateral x-ray films to ensure proper SCS placement are practices that may mitigate malpractice due to SCS. Battery defects and lead complications were the most common grounds for SCS-related malpractice claims.</p></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"2 4","pages":"Article 100376"},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S277259442300208X/pdfft?md5=ebbb45517feb15d2d50f9498c57e75d1&pid=1-s2.0-S277259442300208X-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interventional Pain Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S277259442300208X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Study design
Retrospective cohort study.
Introduction
Malpractice claims analysis is performed by several specialties to improve quality of patient care and to identify areas where physicians can improve their practice to mitigate the incidence of committing malpractice. The Food and Drug Administration has flagged over 80,000 injuries caused by spinal cord stimulator (SCS), making them the 3rd most flagged medical device. This study analyzed malpractice claims due to SCS by querying two legal databases widely used in medicolegal research.
Methods
Westlaw Edge and VerdictSearch were queried for malpractice cases filed between the years 2000 and 2022 using the keywords “spinal cord stimulator.” Case inclusion criteria was defined as a plaintiff's basis of litigation resting on a claim of medical malpractice due to SCS. Additional data collected included date of case hearing, plaintiff sex and age, defendant specialty, verdict ruling, location of the filed claim, payment or settlement amount, and sustained injuries.
Result
Of the 1773 reviewed cases, 45 cases were included and categorized as battery or implantable pulse generator malfunction (35.56 %), lead complications (28.89 %), surgical complications (20.00 %), and miscellaneous (15.56 %). Four (8.89 %) cases resulted in settlement, 11 (24.44 %) in a plaintiff verdict, and 30 (68.00 %) resulted in a defendant verdict. Claims filed due to infection related to SCS were more likely to result in a defendant verdict (p = .047), whereas claims filed due to neurological deficit were more likely to result in a plaintiff verdict (p = .020). The average settlement amount for the 4 cases is $1,975,309.61.
Conclusion
Our findings suggest obtaining adequate neuroimaging preoperatively with MRIs, disclosing neurological risks specifically paralysis on informed consent, and evaluating radiography intraoperative and postoperatively with anterior-posterior (AP) and lateral x-ray films to ensure proper SCS placement are practices that may mitigate malpractice due to SCS. Battery defects and lead complications were the most common grounds for SCS-related malpractice claims.
研究设计回顾性队列研究。医疗事故索赔分析由几个专业执行,以提高患者护理质量,并确定医生可以改进其实践的领域,以减少医疗事故的发生率。美国食品和药物管理局(Food and Drug Administration)已经发现了8万多起由脊髓刺激器(SCS)引起的伤害,使其成为第三大被发现的医疗设备。本研究通过查询医学法学研究中广泛使用的两个法律数据库,分析了由于SCS引起的医疗事故索赔。方法以“脊髓刺激器”为关键词,对2000年至2022年间的医疗事故案件进行检索。案件纳入标准被定义为原告基于由SCS引起的医疗事故索赔的诉讼基础。收集的其他数据包括案件审理日期、原告性别和年龄、被告专业、判决裁决、提起索赔的地点、支付或和解金额以及持续伤害。结果1773例患者中有45例为电池或植入式脉冲发生器故障(35.56%)、引线并发症(28.89%)、手术并发症(20.00%)和杂项(15.56%)。和解案件4起(8.89%),原告判决11起(24.44%),被告判决30起(68.00%)。由于与SCS相关的感染而提出的索赔更有可能导致被告判决(p = 0.047),而由于神经功能缺陷而提出的索赔更有可能导致原告判决(p = 0.020)。这4起案件的平均和解金额为1 975 309.61美元。结论我们的研究结果表明,术前通过mri获得足够的神经成像,在知情同意的情况下披露神经系统风险,并在术中和术后通过前后位(AP)和侧位x线片评估影像学检查,以确保适当的SCS放置,可以减轻由于SCS引起的医疗事故。电池缺陷和铅并发症是scs相关医疗事故索赔中最常见的原因。